elliptinium

This page covers all elliptinium drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Fibroblast growth factor receptor 3, Mast/stem cell growth factor receptor Kit, Platelet-derived growth factor receptor alpha.

Targets

Fibroblast growth factor receptor 3, Mast/stem cell growth factor receptor Kit, Platelet-derived growth factor receptor alpha

Phase 2 pipeline (1)

• Celiptium · Hematology
  Celiptium works by blocking the Kit receptor, which helps control cell growth and division.

Patent intelligence

• elliptinium patent landscape — aggregated cliff calendar, attackable patents, originator estates